Roth Capital analyst Zegbeh Jallah reiterated a Buy rating and $23.00 price target on Ideaya Biosciences (NASDAQ: IDYA) after the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE